BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with BPC 157: Experimental Peptide Creates Risk for Athletes The trend of unproven peptides is spreading through influencers and RFK Jr. allies CNN Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law